Page last updated: 2024-11-02

pentoxifylline and Hepatitis, Animal

pentoxifylline has been researched along with Hepatitis, Animal in 1 studies

Hepatitis, Animal: INFLAMMATION of the LIVER in non-human animals.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with pentoxifylline significantly reduced serum levels of liver enzymes (3800+/-650 vs 150+/-28 IU/l) and tumor necrosis factor alpha (710+/-105 vs 113+/-15 pg/ml) with no evidence of inflammation in histopathologic examination compared to control mice treated with concanavalin A."1.30Pentoxifylline prevents concanavalin A-induced hepatitis by reducing tumor necrosis factor alpha levels and inhibiting adhesion of T lymphocytes to extracellular matrix. ( Aeed, H; Avni, Y; Bruck, R; Frenkel, D; Halpern, Z; Hershkoviz, R; Kenet, G; Shirin, H; Zaidel, L, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shirin, H1
Bruck, R1
Aeed, H1
Frenkel, D1
Kenet, G1
Zaidel, L1
Avni, Y1
Halpern, Z1
Hershkoviz, R1

Other Studies

1 other study available for pentoxifylline and Hepatitis, Animal

ArticleYear
Pentoxifylline prevents concanavalin A-induced hepatitis by reducing tumor necrosis factor alpha levels and inhibiting adhesion of T lymphocytes to extracellular matrix.
    Journal of hepatology, 1998, Volume: 29, Issue:1

    Topics: Animals; Cell Adhesion; Concanavalin A; Extracellular Matrix; Fibronectins; Hepatitis, Animal; Lactu

1998